Publications

Braun, T., Kuschel, F., Reiche, K., Merz, M., & Herling, M. (2025). Emerging T-cell lymphomas after CAR T-cell therapy. Leukemia, 39(6), 1337–1341. https://doi.org/10.1038/s41375-025-02574-x

Ferle, M., Grieb, N., Kreuz, M., Ader, J., Goldschmidt, H., Mai, E. K., Bertsch, U., Platzbecker, U., Neumuth, T., Reiche, K., Oeser, A., & Merz, M. (2025). Predicting progression events in multiple myeloma from routine blood work. NPJ digital medicine, 8(1), 231. https://doi.org/10.1038/s41746-025-01636-9

Braun, T., Rade, M., Merz, M., Klepzig, H., Große, F., Fandrei, D., Pham, N. N., Kreuz, M., Kuhn, C. K., Kuschel, F., Löffler, D., Meinel, J., Heger, E., Schweinsberg, V., Pflug, N., Platzbecker, U., Hallek, M., Holtick, U., Köhl, U., Scheid, C., … Richardson, T. (2025). Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody. Nature medicine, 31(4), 1145–1153. https://doi.org/10.1038/s41591-025-03499-9

Fandrei, D., Seiffert, S., Rade, M., Rieprecht, S., Gagelmann, N., Born, P., Wiemers, T., Weidner, H., Kreuz, M., Schassberger, T., Koßmann, J., Mangold, M., Fürst, D., Fischer, L., Baber, R., Heyn, S., Wang, S. Y., Bach, E., Hoffmann, S., Metzeler, K. H., … Merz, M. (2025). Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma. Blood cancer discovery, 6(1), 38–54. https://doi.org/10.1158/2643-3230.BCD-24-0118

Niarakis, A., Laubenbacher, R., An, G., Ilan, Y., Fisher, J., Flobak, Å., Reiche, K., Rodríguez Martínez, M., Geris, L., Ladeira, L., Veschini, L., Blinov, M. L., Messina, F., Fonseca, L. L., Ferreira, S., Montagud, A., Noël, V., Marku, M., Tsirvouli, E., Torres, M. M., … Glazier, J. A. (2024). Immune digital twins for complex human pathologies: applications, limitations, and challenges. NPJ systems biology and applications, 10(1), 141. https://doi.org/10.1038/s41540-024-00450-5